ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00003034

Locations


United States, Indiana
	CCOP - Northern Indiana CR Consortium
	South Bend, Indiana, United States, 46601

United States, Maryland
	Greenebaum Cancer Center at University of Maryland Medical Center
	Baltimore, Maryland, United States, 21201

United States, Michigan
	Spectrum Health Hospital - Butterworth Campus
	Grand Rapids, Michigan, United States, 49503

United States, Minnesota
	CCOP - Duluth
	Duluth, Minnesota, United States, 55805-1983

United States, Missouri
	Missouri Cancer Care, PC at St. Joseph Health Center - St. Charles
	St. Charles, Missouri, United States, 63301

United States, Nebraska
	Methodist Estabrook Cancer Center
	Omaha, Nebraska, United States, 68114-4199

United States, New Mexico
	University of New Mexico Cancer Research and Treatment Center
	Albuquerque, New Mexico, United States, 87131-5636

Germany
	Asklepios Fachkliniken Muenchen-Gauting
	Gauting, Germany, D-82131
	Asklepios Klinik Harburg
	Hamburg, Germany, D-21075
	Asklepios Klinik St. Georg
	Hamburg, Germany, D-20099
	Hospital Grosshansdorf
	Grosshansdorf, Germany, D-22927
	Klinikum Rechts Der Isar - Technische Universitaet Muenchen
	Munich, Germany, D-81675

Italy
	Fondazione I.R.C.C.S. Policlinico San Matteo
	Pavia, Italy, 27100
	Istituto Nazionale per la Ricerca sul Cancro
	Genoa, Italy, 16132
	Ospedale San Martino
	Genoa, Italy, 16132

Poland
	Klinika Chrorob Pluc I Gruzlicy
	Zabrze, Poland, 41-803
	Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
	Warsaw, Poland, 02-781
	Medical University of Gdansk
	Gdansk, Poland, 80-211
	University School of Medical Sciences
	Poznan, Poland, PL-60 569

Sponsors and Collaborators

Alfacell

Investigators


Study Chair:	Diane Scudiery	Alfacell